Market Cap: 12,09,865 Cr.
CMP: Rs.3,306 | P/E: 29x TTM
Results |
INR Cr. |
Y-o-Y Growth |
Comments |
Revenue |
58,229 |
19.1% |
Growth was led by Retail and Consumer Packaged Goods (+18.7%) and Life Sciences & Healthcare verticals (+14.4%). |
EBIT |
14,284 |
16.7% |
Margin decreased to 24.5% (-0.5% Y-o-Y) |
PAT |
10,846 |
11.0% |
Net Margin came in at 18.6% from 20.0% (Y-o-Y) |
Key Highlights:
·TCV of new deals won during the quarter was $7.9 Bn, a decrease from $8.1 Bn last quarter. While Book to Bill was at 1.1
·Total headcount at 613,974; shedding 2,197 employees, first headcount reduction in 10 Quarters; LTM attrition was at 21.3%.
·Company has declared a dividend of Rs. 75 per share including Rs. 67 as special dividend.
Management Outlook:
·The company is eyeing an EBIT margin of 25% by end of FY23 thus further margin expansion of 50 bps is expected by Q4 FY23.
·While the global macro situation hasn’t changed significantly, management has indicated greater confidence about the demand situation in US & UK but has a cautious outlook on Europe business.
·Net hiring in the last quarter was significantly ahead of revenue growth, going forward the company will be focusing on utilizing all the excess capacity.